PubMed Health⌕ Search

Biomedical subjects

S L Quinn

Publications and source records attributed to S L Quinn.

5 recordsLinked to original sources

Stability of cimetidine hydrochloride in admixtures after microwave thawing.

The stability of cimetidine hydrochloride in admixtures subjected to freezing and subsequent microwave thawing was studied. Admixtures containing cimetidine 300 mg were prepared using 18 50-ml bags of 5% dextrose injection and 18 100-ml bags of 0.9% sodium chloride injection. A sample for analysis of pH and drug concentration was withdrawn from each bag, and all admixtures were frozen for 28 days. Nine admixtures of each solution were thawed at room temperature and the other nine in a microwave oven until a final solution temperature of 24 +/- 2 degrees C was reached. An additional five cimetidine admixtures in 0.9% sodium chloride injection were prepared and irradiated in the microwave oven until boiling occurred for five seconds. Samples of all admixture solutions were withdrawn within 30 minutes of thawing and again at 24 +/- 2 hours after thawing to determine pH and cimetidine concentration. Concentrations were measured by high-performance liquid chromatography. Admixtures pH after thawing did not vary substantially from baseline values. A significant difference in cimetidine concentration for each solution was observed between samples drawn at 0 and 24 hours after thawing; drug concentrations in 5% dextrose increased by 5.9% while those in 0.9% sodium chloride decreased by 1.5%. Thawing method had no significant effect on drug concentration in either admixture solution. In the solutions and drug concentrations tested, microwave thawing did not affect cimetidine stability. Increases in cimetidine concentrations in 5% dextrose solution may have been attributable to greater insensible water losses produced by heating of the small 50-ml bags.

Chromatography, High Pressure Liquid↗

Nitroglycerin intravenous infusion.

The treatment of various cardiovascular problems with intravenous nitroglycerin is widely practiced though unapproved. The uses of iv nitroglycerin include improvement of the hemodynamics of left ventricular failure and cardiogenic shock associated with infarction, control of hypertension during coronary artery surgery, and possibly, reduction of acute myocardial infarct size. The popularity of this treatment in the absence of an FDA-approved commercial product has forced some hospitals to prepare the drug extemporaneously, and the advantages and disadvantages of preparation and storage techniques are presented.

Drug Stability↗